Gene Expression Profiles as Markers of Aggressive Disease-EGFR as a Factor

International Journal of Radiation Oncology Biology Physics

Volumn 69, Issue 2 SUPPL., 2007, Pages

  Chung, Christine H ^a   Parker, Joel ^b   Levy, Shawn ^a   Slebos, Robbert J ^a   Dicker, Adam P ^c   Rodeck, Ulrich ^c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GENE PRODUCT;

ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ACTIVITY; DOWN REGULATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LIGAND BINDING; OVERALL SURVIVAL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

CARCINOMA, SQUAMOUS CELL; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 34548432683     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.05.039     Document Type: Article

References (13)

1. Arteaga C.L. Targeting HER1/EGFR: A molecular approach to cancer therapy. Semin Oncol 30 (2003) 3-14
2. Arteaga C.L. ErbB-targeted therapeutic approaches in human cancer. Exp Cell Res 284 (2003) 122-130
3. Albanell J., Codony-Servat J., Rojo F., et al. Activated extracellular signal-regulated kinases: Association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments. Cancer Res 61 (2001) 6500-6510
4. Grandis J.R., and Tweardy D.J. TGF-alpha and EGFR in head and neck cancer. J Cell Biochem Suppl 17F (1993) 188-191
5. Grandis J.R., Melhem M., Gooding W., et al. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. J Natl Cancer Inst 90 (1998) 824-832
6. Chung C.H., Ely K., McGavran L., et al. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas. J Clin Oncol 24 (2006) 4170-4176
7. Boukamp P., Petrussevska R.T., Breitkreutz D., et al. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106 (1988) 761-771
8. Quadros M.R., Peruzzi F., Kari C., et al. Complex regulation of signal transducers and activators of transcription 3 activation in normal and malignant keratinocytes. Cancer Res 64 (2004) 3934-3939
9. Heid C.A., Stevens J., Livak K.J., et al. Real time quantitative PCR. Genome Res 6 (1996) 986-994
10. Chung C.H., Parker J.S., Karaca G., et al. Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 5 (2004) 489-500
11. Chung C.H., Parker J.S., Ely K., et al. Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-{kappa}B signaling as characteristics of a high-risk head and neck squamous cell carcinoma. Cancer Res 66 (2006) 8210-8218
12. Sergina N.V., Rausch M., Wang D., et al. Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3. Nature 445 (2007) 437-441
13. Zhou B.B., Peyton M., He B., et al. Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer. Cancer Cell 10 (2006) 39-50